BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15616874)

  • 1. Chemoradiotherapy for esophageal cancer: current status and perspectives.
    Ohtsu A
    Int J Clin Oncol; 2004 Dec; 9(6):444-50. PubMed ID: 15616874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
    Ohtsu A
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative therapy for esophageal cancer.
    Ku GY; Ilson DH
    Gastroenterol Clin North Am; 2009 Mar; 38(1):135-52, ix. PubMed ID: 19327572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
    Yano M; Inoue M; Shiozaki H
    Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant therapy of esophageal cancer.
    Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
    Ku GY; Ilson DH
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of chemotherapy for esophageal carcinoma.
    Ilson D
    Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radio- and chemotherapy of cancer of the esophagus].
    Tiret E
    Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
    Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy.
    Iyer R; Wilkinson N; Demmy T; Javle M
    Ann Surg Oncol; 2004 Jul; 11(7):665-73. PubMed ID: 15197012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy].
    Ando N; Ozawa S; Kitagawa Y; Takeuchi H; Kitajima M
    Nihon Geka Gakkai Zasshi; 1997 Sep; 98(9):767-72. PubMed ID: 9370137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemoradiotherapy for esophageal cancer].
    Fujita H; Sueyoshi S; Tanaka T; Sasahara H; Matono S; Yamana H; Shirouzu K; Suzuki G; Hayabuchi N
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):937-43. PubMed ID: 12894707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoadjuvant chemoradiotherapy for advanced esophageal cancer].
    Natsugoe S; Matsumoto M; Okumura H; Uchikado Y; Setoyama T; Kita Y; Arigami T; Uenosono Y; Owaki T; Ishigami S
    Nihon Geka Gakkai Zasshi; 2011 Mar; 112(2):111-6. PubMed ID: 21488344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of chemoradiotherapy and surgical resection for cT4 esophageal cancer.
    Morita M; Toh Y; Saeki H; Sugiyama M; Ohgaki K; Maehara S; Minami K; Ikeda Y; Sakaguchi Y; Okamura T; Uehara S; Maehara Y
    Anticancer Res; 2012 Aug; 32(8):3275-82. PubMed ID: 22843902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.